Pig kidney functions for record 271 days inside man awaiting human transplant
Researchers say the success story of Tim Andrews shows how pig kidneys can help “bridge the gap between end-stage kidney failure and a human transplant, allowing a patient to forgo dialysis."
Researchers say the success story of Tim Andrews shows how pig kidneys can help “bridge the gap between end-stage kidney failure and a human transplant, allowing a patient to forgo dialysis."
Recalled weight loss products are tainted with toxic substance, FDA says
A product sold for weight loss has been recalled because it contains toxic substances that can cause “a wide range of serious and potentially life-threatening adverse effects.”
A product sold for weight loss has been recalled because it contains toxic substances that can cause “a wide range of serious and potentially life-threatening adverse effects.”
Groundbreaking pancreatic cancer drug approved by FDA: What we know
The Food and Drug Administration has approved a landmark new drug for advanced pancreatic cancer, one of the deadliest types of the disease.
The Food and Drug Administration has approved a landmark new drug for advanced pancreatic cancer, one of the deadliest types of the disease.
Costco to sell branded Medicare plans in new pilot program
Costco is partnering with nonprofit insurer SCAN Group to pilot Costco-branded Medicare plans that integrate coverage with several of the retailer’s health services.
Costco is partnering with nonprofit insurer SCAN Group to pilot Costco-branded Medicare plans that integrate coverage with several of the retailer’s health services.
Roughly 23 million Americans trapped in jobs they want to leave over one costly fear
Nearly one in four American workers with employer-sponsored health insurance say they are stuck in jobs they want to leave because they fear losing coverage.
Nearly one in four American workers with employer-sponsored health insurance say they are stuck in jobs they want to leave because they fear losing coverage.
Eli Lilly offers new weight loss drug to some patients before FDA approval
Eli Lilly will allow a limited number of patients early access to retatrutide, its next-generation weight loss drug, before it gets FDA approval.
Eli Lilly will allow a limited number of patients early access to retatrutide, its next-generation weight loss drug, before it gets FDA approval.
Moderna’s mRNA flu vaccine gets FDA approval: Here's what's different
The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.
The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.
VA launches trial of GLP-1 drugs to treat alcohol use disorder in veterans
The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans.
The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans.
Here's how much retiring in 2026 could cost you in health care expenses
A new Fidelity Investments analysis finds that health care costs for Americans retiring in 2026 are expected to rise 7.5% from last year.
A new Fidelity Investments analysis finds that health care costs for Americans retiring in 2026 are expected to rise 7.5% from last year.
Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads
Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy.
Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy.
Former NFL star Chris Johnson reveals ALS battle
Former NFL star Chris Johnson, 40, recently announced he was diagnosed with ALS. Johnson ran for 2,000 yards in his second season with the Tennessee Titans in 2009 on his way to three consecutive Pro Bowl appearances. He was also named the 2009 Offensive Player of the Year. LiveNOW’s Anna Marsick is speaking with Dr. Imad Najm, a Cleveland Clinic Neurologist, to learn more about Johnson’s battle and the rise in neurological diseases that are impacting aging populations.
Former NFL star Chris Johnson, 40, recently announced he was diagnosed with ALS. Johnson ran for 2,000 yards in his second season with the Tennessee Titans in 2009 on his way to three consecutive Pro Bowl appearances. He was also named the 2009 Offensive Player of the Year. LiveNOW’s Anna Marsick is speaking with Dr. Imad Najm, a Cleveland Clinic Neurologist, to learn more about Johnson’s battle and the rise in neurological diseases that are impacting aging populations.
Arizona toddler found alive in hospital morgue after being declared dead
An 18-month-old Gilbert boy was found breathing in a hospital morgue nearly five hours after being declared dead following a pool incident.
An 18-month-old Gilbert boy was found breathing in a hospital morgue nearly five hours after being declared dead following a pool incident.
Obamacare premiums going up next year - Here's why
Millions of Americans who buy health insurance through the Affordable Care Act marketplace could face another year of higher premiums in 2027.
Millions of Americans who buy health insurance through the Affordable Care Act marketplace could face another year of higher premiums in 2027.
Worried about 'Ozempic butt?' New drug could stop muscle loss tied to weight loss injections
A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.
A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.
Medicare rolls out $50 GLP-1 drug program: What to know
GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 program.
GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 program.
455 charged in health care fraud crackdown; schemes totaled over $6.5 billion
Over 400 people, including 90 medical professionals, were charged in connection with medical fraud schemes, the DOJ announced.
Over 400 people, including 90 medical professionals, were charged in connection with medical fraud schemes, the DOJ announced.
TrumpRx list expanded again and tops 800 drugs, president says
President Trump said more than 800 drugs are now listed on his TrumpRx site.
President Trump said more than 800 drugs are now listed on his TrumpRx site.
Experimental pill helps people with advanced pancreatic cancer live longer, researchers say
An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.
An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.
These states spend the most on health care: See the list
A new WalletHub report found Americans are spending significantly more on health care.
A new WalletHub report found Americans are spending significantly more on health care.
CVS Caremark to cover Zepbound again after lawsuit, widespread backlash
CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.
CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.